Objectives: Women with a history of preeclampsia have an increased risk for cardiovascular diseases 20 later in life. Persistent vascular alterations in the postpartum period might contribute to this 21 increased risk. The current study assessed arterial stiffness under low sodium (LS) and high sodium 22 (HS) conditions in a well-characterized group of formerly early-onset preeclamptic (fPE) women and 23 formerly pregnant (fHP) women. 24
week of LS (50 mmol Na + /day) and one week of HS (200 mmol Na + /day) intake. Arterial stiffness was 26 measured by pulse wave analysis (aortic augmentation index, AIx) and carotid-femoral pulse wave 27 velocity (PWV). Circulating markers of the renin-angiotensin aldosterone system (RAAS), extracellular 28 volume (ECV), nitric oxide (NO) and hydrogen sulfide (H 2 S) were measured in an effort to identify 29 potential mechanistic elements underlying adaptation of arterial stiffness. 30
Results: AIx was significantly lower in fHP women on LS compared to HS while no difference in AIx 31 was apparent in fPE women. PWV remained unchanged upon different sodium loads in either group. 32 INTRODUCTIONshowed no differences in glomerular filtration rate (GFR; measured by 125 -I-iothalamate) and no 97 differences in renal hemodynamic response to angiotensin II infusion between groups, but the study 98 did reveal a higher filtration fraction (FF) in the fPE group on both LS and HS diet (48). The study 99 population was selected from the electronic delivery database of the department of Obstetrics and 100
Gynecology at the University Medical Center Groningen. Preeclampsia was defined according to the 101 definition of the International Society for the Study of Hypertension in Pregnancy (2), and early-onset 102 preeclampsia was defined as developing preeclampsia before 34 weeks of gestation. Participants 103 without comorbidity were selected by the exclusion of women with renal disease, diabetes or a 104 history of gestational diabetes, obesity (BMI>30 kg/m 2 at screening) and women using 105 antihypertensive medication. Additional exclusion criteria were pregnancy, current lactation and 106 post-menopausal status. None of the women included were using oral contraceptives. A control for 107 each preeclamptic women was selected using the following selection criteria: same parity, age 108 (within one year) and year of index pregnancy (within one year). All subjects were non-smokers and 109 normotensive, having a sitting systolic blood pressure <140mmHg and diastolic blood pressure 110 <90mmHg measured by Dinamap (an average of three measurements was taken). All patients 111 underwent physical examination and electrocardiography at enrolment into the study, which did not 112 reveal any abnormalities. The study was approved by the local ethics committee (Medical Ethical 113
Committee UMCG Groningen, the Netherlands; number 2010/294), and all subjects gave written 114 informed consent. For this cross-over study a multivariate power calculation with three factors and 115 wave velocity (PWV). The PWV was determined by sequential acquisition of pressure waveforms 148 from the carotid and the femoral arteries. The timing of these waveforms was synchronized with that 149 of the R-wave on the simultaneously recorded ECG. To minimize the influence of body contour, the 150 proximal distance was measured from the sternal notch to the sampling site on the carotid artery 151 and the distal distance was measured from the acromial angle to the sampling site on the femoral 152 artery. The average of more than 8 successive measurements was used in the analysis to cover a 153 complete respiratory cycle. Plasma sulfide levels were semi-quantified using a standard curve produced from a dilution series of 187 NEM derivatized Na 2 S. The standard was used to verify the elution time and fragmentation pattern of 188 the sulfide adduct. Urine samples were drawn from the 24-hour urine and the levels of sodium, 189 potassium and urea were assessed by the use of an automated clinical chemistry analyzer ( was performed for AIx, AIx@75, PWV, MAP and ECV to separately test the effects of history of 199 preeclampsia (factor group) and sodium intake (factor diet). In addition, this analysis enabled us to 200 separately study the changes in parameters in response to change in diet within the fHP and fPE 201 group. The same GEE analysis was performed to analyze plasma nitrate, RxNO, cGMP, and total 202 sulfide. To determine whether age is a determinant of arterial stiffness we used linear regression, 203 which was performed for both LS and HS diet. Differences were considered significant if p<0.05. ratio did not significantly differ between groups. Urinary sodium concentrations showed that the 217 dietary compliance during LS and HS diet was excellent in both groups. No statistically significant 218 differences in potassium and urea excretion were found between the groups reflecting an equal 219 intake of potassium and proteins. Serum sodium did not differ between fHP and fPE women on 220 either LS or HS diet. No differences in PRA and aldosterone were found between groups, and the 221 changes in PRA and aldosterone in response to low sodium intake was similar in both groups. All 222 women were normotensive at the time of the screening visit, and there were no significant 223 differences in mean baseline 2-hour blood pressure, aortic mean pressure, pulse pressure and 224 ECV/BSA measured after LS diet and HS diet week (47). Both fHP and fPE women demonstrated a 225 significant higher blood pressure and ECV/BSA on HS as compared to LS and the GEE-analyses 226 showed that differences in blood pressure and ECV/BSA between HS and LS were similar between 227
groups. 228 229

Changes in arterial stiffness as a function of sodium load 230
Arterial stiffness in fHP and fPE on LS and HS intake expressed as AIx and PWV is shown in Figure 1A -231 C. No differences for AIx between fHP and fPE were found on both LS and HS conditions. However 232 the GEE-analysis showed that LS intake was associated with a significant lower AIx compared to HS 233 intake in fHP women (p diet*fHP = 0.016) while no difference in AIx between LS and HS intake was 234 observed in fPE women. As for AIx, there were no differences between the groups on LS and HS, but 235
Changes in endothelial function markers 244
Both NO and H 2 S are produced by endothelial cells to regulate vascular tone and arterial stiffness. 245
We therefore measured plasma nitrate, RxNO and cGMP (NO related read-outs) and total sulfide 246 (H 2 S related metabolite) as markers of endothelial function in fHP and fPE women (Figure 2A-D) . GEE 247 analysis for nitrate showed no significant differences between groups, buton LS intake nitrate 248 concentrations were significantly higher compared to HS in both groups (p diet*fHP = 0.016, p diet*fPE = 249 0.04). We did not find differences in RxNO, cGMP and sulfide concentrations between diet and 250 groups, in part presumably due to the rather large inter-individual variation in circulating biomarker 251 levels observed. 252 without any comorbidity, under standardized low and high sodium conditions. We demonstrated 258 that fPE women have an impaired ability to adapt their arterial stiffness (AIx and AIx@75) upon low 259 sodium diet compared to fHP women. The non-adaptation of arterial stiffness could not be explained 260 by differential responses between fHP and fPE women in blood pressure, circulating RAAS 261 components, extracellular volume expansion, and plasma concentrations of nitrate, RxNO, cGMP, 262 and sulfide. Increased arterial stiffness is known to be associated with the development of 263 hypertension and cardiovascular diseases (4, 21, 28, 32). An impaired ability to decrease AIx in 264 response to sodium status in fPE women might be a first indication of an unfavorable vascular 265
profile. 266
While both AIx and PWV were similar in fHP and fPE women on LS and HS diet, AIx and 267
AIx@75 were lower on LS diet compared to HS diet in fHP-women but not in fPE-women. We are the 268 first to show this non-adaptation of arterial stiffness in a well-controlled setting, studying subjects at 269 risk for premature vascular disease and healthy controls in the absence of any comorbidity. LS diet 270 normally reduces arterial stiffness; as shown earlier by a meta-analysis exploring the effect of dietary 271 and nutritional interventions on arterial stiffness (34) and by a study in (postmenopausal) female 272 hypertensive subjects (44). Our findings of non-adaptation of arterial stiffness in response to LS in fPE 273 thus suggests that fPE women lost the capability to adjust arterial stiffness upon LS intake. 274
Previous studies on arterial stiffness in fPE women were not performed under standardized 275 dietary conditions and did not standardize for phase of menstrual cycle. Assuming that sodium intake 276 in the previous studies is in the range of average intake in the Western diet, these studies are 277 comparable with our HS condition under which we observed no differences in AIx and PWV between 278 groups. Under this assumption, our results are in line with two other studies that showed no 279 differences in AIx in fPE women compared to controls (25, 39). However, other studies have reported 280 fPE women. These conflicting findings are likely a result of differences in study design, heterogeneity 282 of the preeclamptic phenotype, and variable presence of comorbidities (e.g. hypertension and 283 increased BMI). The strength of our study is that we studied a well-characterized group of healthy 284 fPE women under standardized dietary conditions compared to a control group with the same parity, 285 age and year of index pregnancy. Therefore, we can conclude that fPE women without comorbidity 286 do not differ in arterial stiffness compared to fHP women on a regular Western diet. 287
Our finding of non-adaptation of arterial stiffness upon LS diet was only reflected in AIx and 288 not in the PWV measurements. This might be explained by the different (age-related) vascular 289 responses that these measures represent (29). In general, PWV is affected by structural vascular 290 changes such as narrowing and sclerosis of the vessels that occur during the later phase of 291 atherosclerosis. The central AIx is a measure of arterial wave reflection which depends both on the 292 PWV and intrinsic properties of the vessel wall. While PWV is the gold standard for measurement of 293 arterial stiffness(49), AIx was found to be correlated with diverse cardiovascular risk factors at a 294 young age, in the absence of structural vascular changes (6, 50). In addition, vasoactive drugs 295 influence AIx independent of PWV which shows that wave reflection is influenced by small-artery 296 tone/structure (22). According to this evidence, AIx might be more suitable compared to PWV in 297 detecting early stage vascular dysfunction based on sensitivity to detect functional vessel 298
abnormalities. 299
Increased arterial stiffness is a result of aging (changes in extracellular matrix composition) 300 (23) and is associated with hypertension, diabetes mellitus, atherosclerosis and renal failure (35, 40). 301
We carefully excluded these factors from our study design by comparing our fPE group with a control 302 group of the same age and by the exclusion of women with co-morbidity. To overcome the 303 influences of differences in sodium intake on arterial stiffness we had an excellent standardization of 304 the diets as observed in the urinary sodium values. On both LS and HS serum sodium did not 305 significantly differ between fHP and fPE but there was a slightly different response of serum sodiumto the change in diet within groups (fHP LS vs HS p<0.05, while fPE LS vs HS ns; p values earlier notaffected by dietary sodium intake and could therefore be mechanisms underlying the observed non-312 adaptation of arterial stiffness in response to sodium (9). However, we did not detect any differences 313 in circulating RAAS markers between groups; moreover, we found that the systemic RAAS was 314 adequately modulated by sodium intake in both groups as observed by a similar increase in PRA and 315 aldosterone in response to LS in our study. Our ECV data show that both the fHP and fPE group are 316 reducing their ECV upon LS to a similar extent. As expected, reducing extracellular volume resulted in 317 a reduction in arterial stiffness in fHP women, illustrating the ability of healthy vessels to shift 318 stiffness along their compliance curve in response to volume reduction. Since non-adaptation of 319 arterial stiffness was observed in fPE women, we hypothesize that fPE women have stiffer vessels 320 that already work at the upper end of their compliance having less adaptability upon extrinsic 321
factors. 322
With respect to endothelial function, the production of the 'gasotransmitters' NO and H 2 S 323 plays an important role in the control of vascular tone (30, 56). While endothelial NO production is 324 also a key regulator of arterial stiffness (54), little is currently known about the biological significance 325 of H 2 S in this context. Nevertheless, there is ample cross-talk between these mediators at the 326 functional and chemical level with sulfide affecting NO bioavailability (7). Plasma nitrate, RxNO, 327 cGMP and sulfide did not differ between groups, while both fHP and fPE women showed an increase 328 in plasma nitrate on LS. Plasma nitrate is the final end product of NO metabolism, thus suggesting 329 enhanced endogenous NO production upon LS intake. In this study we were limited to plasma 330 analysis and we analysed the circulating components in a relatively small number of patients with 331 large inter-individual variation which might explain the lack of trend observed in cGMP while we do 332 observe a trend in nitrates. While the true levels of H 2 S related metabolites in blood are currently a 333 matter of lively debate, total plasma sulfide concentrations are, at least in part, likely of endothelial 334 origin but do not seem to change upon changes in sodium load. Based on our findings we cannot 335 conclude with certainty that endothelial function is not involved in the non-adaptation of arterial 336 stiffness, as circulating levels do not necessarily reflect vascular tissue concentrations. A limitation of 337 our study is that we did not assess flow-mediated dilatation (FMD), the gold standard to assess 338 endothelial function. Previous work suggests that fPE women have an impaired FMD compared to 339 controls (5, 16, 18, 33, 43, 58) and this might be a mechanism associated with non-adaptation of 340 arterial stiffness under LS. 341
Future studies should investigate the mechanistic pathways behind the non-adaptation of 342 arterial stiffness in fPE women and should include arterial stiffness measurements in combination 343 with FMD. It would be of interest to characterize the structure and character of the vessel wall and 344 endothelial surface layer (glycocalyx). The glycocalyx plays an important role in both sodium 345 homeostasis and regulation of arterial stiffness. Under high sodium conditions, endothelial sodium 346 channels are upregulated resulting in an increased sodium influx in the endothelial cells, which leads 347 to increased stiffness (24). Defects in the glycocalyx might result in increased arterial stiffening under 348 LS condition by increased access of sodium via endothelial sodium channels with subsequently 349 reduced NO release causing reduced arterial stiffness and vasoconstriction (13, 24). In addition, the 350 question whether inability to adapt arterial stiffness in response to LS was pre-existing or induced by 351 preeclampsia remains to be answered. 352
In conclusion, the current study is the first to show an effect of non-adaptation of arterial 353 stiffness in fPE women in response to sodium intake. We could not explain the non-adaptation by 354 differences in blood pressure, plasma RAAS parameters, ECV, circulating markers of NO production 355 and availability or plasma sulfide as a read-out of H 2 S activity. The exact underlying pathways 356 involved in the non-adaptation in fPE women therefore remains to be elucidated. However, 357 independent of the underlying mechanisms, impaired adaptation of arterial stiffness in response to 358 sodium intake might be a marker of subclinical vascular damage in fPE women without comorbidity. 359
We propose that non-adaptation in response to sodium intake is a first sign of unfavorable vascular 360 alterations in fPE women, which might put them at risk to develop hypertension and cardiovascular 361 disease. 362
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